Stratos Wealth Advisors LLC acquired a new stake in shares of Canopy Growth Co. (NASDAQ:CGC – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 20,106 shares of the company’s stock, valued at approximately $97,000.
Several other large investors have also recently bought and sold shares of CGC. Vontobel Holding Ltd. bought a new position in shares of Canopy Growth during the 3rd quarter valued at about $92,000. Mackenzie Financial Corp lifted its stake in Canopy Growth by 13.2% in the second quarter. Mackenzie Financial Corp now owns 33,165 shares of the company’s stock valued at $214,000 after buying an additional 3,864 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Canopy Growth by 168.6% in the second quarter. Squarepoint Ops LLC now owns 91,227 shares of the company’s stock valued at $588,000 after buying an additional 57,262 shares during the period. Insigneo Advisory Services LLC bought a new stake in shares of Canopy Growth during the second quarter worth $96,000. Finally, Farallon Capital Management LLC bought a new stake in Canopy Growth in the 2nd quarter valued at $194,000. Institutional investors own 3.33% of the company’s stock.
Canopy Growth Stock Performance
Shares of CGC stock opened at $5.04 on Thursday. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 1.05. Canopy Growth Co. has a 12 month low of $2.76 and a 12 month high of $14.92. The company’s fifty day simple moving average is $4.97 and its 200-day simple moving average is $6.90. The firm has a market cap of $384.04 million, a PE ratio of -0.79 and a beta of 0.86.
Wall Street Analyst Weigh In
Separately, Piper Sandler dropped their price target on Canopy Growth from $3.00 to $2.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 9th.
Read Our Latest Stock Report on CGC
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Featured Stories
- Five stocks we like better than Canopy Growth
- How to Evaluate a Stock Before BuyingÂ
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Dividend Payout Ratio Calculator
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.